SILICON LABORATORIES INC.
SLABdata completeness 88%18 fiscal years on fileSILICON LABORATORIES INC. earns about -3% on invested capital, and has bought back 26% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $720.9M1 | $1.02B2 | $782.3M3 | $584.4M3 | $784.8M3 |
| Net income | $2.12B4 | $91.4M4 | −$34.5M5 | −$191M5 | −$64.9M5 |
| Operating cash flow | $91.2M6 | $141.3M7 | −$30.3M8 | −$13.9M8 | $95.7M8 |
| Capital expenditure | $28.6M9 | $26.5M10 | $22.3M11 | $11.7M11 | $29.9M11 |
| Free cash flow (derived) | $62.6M6 | $114.7M7 | −$52.6M8 | −$25.7M8 | $65.8M8 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $1.07B12 | $499.9M13 | $227.5M14 | $281.6M15 | $364.2M15 |
| Diluted shares | 44.3M | 36.0M | 31.8M | 32.2M | 32.7M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $334.47 of net worth that earned you −$19.84 and generated $20.11 of cash last year.
It earned an average -3% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 26% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-01-01 · accession 0001104659-24-025535 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001038074-25-000003 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-30 · accession 0001038074-26-000005 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-01-01 · accession 0001104659-24-025535 (ProfitLoss)
- 10-K · period ending 2023-12-30 · accession 0001038074-26-000005 (NetIncomeLoss)
- 10-K · period ending 2022-01-01 · accession 0001104659-24-025535 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
- 10-K · period ending 2022-12-31 · accession 0001038074-25-000003 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
- 10-K · period ending 2023-12-30 · accession 0001038074-26-000005 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-01-01 · accession 0001104659-24-025535 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001038074-25-000003 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-30 · accession 0001038074-26-000005 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-01-01 · accession 0001104659-23-009254 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001104659-24-025535 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-30 · accession 0001038074-25-000003 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-28 · accession 0001038074-26-000005 (CashAndCashEquivalentsAtCarryingValue)